Complex Genotype Sarcomas Display Familial Inheritance Independent of Known Cancer Predisposition Syndromes

Sarcoma Services, Department of Orthopaedics, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA.
Cancer Epidemiology Biomarkers & Prevention (Impact Factor: 4.13). 02/2011; 20(5):751-7. DOI: 10.1158/1055-9965.EPI-10-1174
Source: PubMed


The low incidence of sarcomas in the general population makes heritable contribution to disease risk difficult to discern beyond highly penetrant Mendelian syndromes.
The Utah Cancer Registry (UCR) and Utah Population Database were interrogated for sarcoma diagnostic codes grouped by genetic type, either complex genotype/karyotype sarcoma or balanced translocation-associated sarcoma. The genealogic index of familiality (GIF) was calculated and relative risks (RR) of disease estimated for first-, second-, and third-degree relatives of sarcoma probands. Cancer patterns in pedigrees of sarcoma probands were examined to rule out known hereditary cancer syndromes.
A total of 229 balanced translocation type and 1,161 complex genotype type sarcomas with at least three generations of ancestral genealogy data were identified in the UCR. There was no evidence for excess relatedness for the balanced translocation group by using the GIF test (P = 0.657) and no significantly elevated RRs. In the complex genotype group, we observed significantly elevated GIF (P = 0.03). Modest RRs corroborated the GIF analysis, in which excess relatedness existed in distant relationships. No recognized cancer syndromes were identified among high-risk pedigrees.
We identified strong familiality among complex genotype sarcomas, independent from known cancer predisposition syndromes. In the absence of significantly elevated RRs for close relatives, the high GIF argues for a strong genetic-rather than environmental-component to complex genotype sarcoma risk. We observed no significant familial risk of developing balanced translocation-associated sarcomas, but the sample was small.
There exists yet to be deciphered heritable risk for developing complex genotype sarcomas.

Download full-text


Available from: Wendy Kohlmann, Oct 07, 2015
22 Reads
  • Source
    • "Shared risk factors for the development of lymphoma and sarcoma, including acquired immunodeficiency and herbicide exposure may exist [7]. In a case-control study assessing risk factors for the development of soft tissue sarcoma, excess lymphoma and specifically Hodgkin's (OR 8.9, 95% CI 1.7-51.2) was noted among sarcoma relatives [25]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Sarcomas are rare, often fatal malignancies of connective tissues that can occur in genetic predisposition syndromes or result from carcinogen exposure. Hodgkin's lymphoma (HL) is not known to contribute to any recognised familial cancer syndrome comprising sarcomas, but is known to be associated with a variety of second cancers, including sarcomas. This study describes the prevalence of HL in families affected by sarcoma. The International Sarcoma Kindred Study (ISKS) is a prospective cohort of 561 families ascertained via a proband with adult-onset sarcoma. Cancer-specific standardised incidence ratios (SIR) for multiple primary malignancies in probands were estimated. Clinical characteristics of individuals reporting both sarcoma and HL were described. Standardised incidence ratios for the occurrence of cancer in ISKS families were also estimated. Multiple primary cancers were reported in 16% of probands, significantly higher than in the general population. The risk of HL in probands was increased 15.8-fold (95%CI 7.9-31.6) and increased risks were also seen for breast cancer (SIR 2.9, 95%CI 1.9-4.4) and thyroid cancer (SIR 8.4, 95%CI 4.2-16.8). In 8 probands with both HL and sarcoma, the diagnosis of HL preceded that of sarcoma in 7 cases, and occurred synchronously in one case. Only 3 cases of sarcoma occurred in or close to prior radiotherapy fields. The overall incidence of HL in the ISKS cohort was not significantly increased by comparison with age- and gender-specific population estimates (SIR 1.63, 95%CI 1.05-2.43), suggesting that the association between HL and sarcomas did not extend to other family members. The age of onset of non-sarcoma, non-HL cancers in families affected by both HL and sarcoma was younger than the general population (56.2 y vs 65.6 y, P < 0.0001). The basis for the association between HL and sarcomas may include the carcinogenic effects of therapy combined with excellent survival rates for HL. Common risk factors for both may also exist, including both environmental and heritable factors.
    01/2012; 2(1):1. DOI:10.1186/2045-3329-2-1
  • [Show abstract] [Hide abstract]
    ABSTRACT: We used the Utah Population Database to examine risk of cancer in relatives of 4482 pediatric cancer cases (≤18 years old) diagnosed from 1966-2009 compared to matched population controls. We quantified cancer risk in relatives of children with cancer to determine evidence of familial aggregation and to inform risk assessment and counseling for families. Odds ratios that reflect risk were obtained using conditional logistic regression models adjusting for number of biological relatives, their degree of genetic relatedness, and their person-years at risk. First-degree relatives (primarily siblings) of pediatric cases faced a 2-fold increased risk of a cancer diagnosis before age 19, which extended to their second-degree relatives (P<10(-4) , respectively). Furthermore, first-degree relatives of children diagnosed before age 5 had a 3.6-fold increased risk of developing pediatric cancer (P<10(-7) ), second-degree relatives of very young (under age 5) cases were at 2.5-fold risk (P<10(-4) ), and third-degree relatives were at 2-fold risk (P<10(-3) ) of childhood cancer. While first-degree relatives of pediatric cases have a slight increased risk of adult tumors, when they do develop cancer they have a 1.7-fold risk of developing a tumor in the Li-Fraumeni spectrum. Our findings support the hypothesis of familial aggregation in pediatric cancer and suggest a higher percent of childhood cancers may be related to hereditary syndromes than are adult cancers. We encourage the collection of a family medical history that is routinely updated for all pediatric cancer patients, and that families with early onset adult cancers or clusters of several cancers are referred for genetic counseling. © 2013 Wiley Periodicals, Inc.
    International Journal of Cancer 11/2013; 133(10). DOI:10.1002/ijc.28266 · 5.09 Impact Factor